Breast+ CNS consultant

This is a replacement post created to replace several retiring consultants or those reducing their workload. The post is full time, comprising 10 PAs in total, but candidates who do not wish to work full time for personal reasons will be eligible to be considered for the post. The site specialist focus of the post will be upper gastrointestinal, melanoma malignancies and sarcoma.

The successful applicant will join the existing lung and UGI oncology teams based in the James Cook Cancer Institute (JCCI) at the James Cook University Hospital (JCUH). The post-holder will manage Breast cancers at South Tees and Hartlepool Hospital working with the consultant team and ACP's, providing radiotherapy and systemic treatments for UGI malignancies. The post will include attendance at weekly MDTs, clinics to see new and follow-up patients, radiotherapy planning sessions and clinical administration sessions for chemotherapy prescribing and correspondence. Research is very important to the department and the post-holder will be expected to work with the clinical research team to optimise trial recruitment., Maintain the highest clinical standards in the practice of Clinical Oncology

Clinical/ on-call responsibilities

Undertake any responsibility which relates to the agreed special interests

Cover for colleagues' annual leave and other authorised absences

Provide professional supervision and management of junior medical staff

Be actively involved in the management of the department including attendance at monthly Directorate/Consultant meetings

Take part in annual appraisals (mandatory for all Consultants). Appropriate time and assistance will be provided for preparation.

Active involvement in audit

Involvement in research.

Continuing professional development.

Any other duties which may be required

Contribute to the on-call system rota (see below)

With state-of-the-art radiotherapy facilities at James Cook University Hospital including IGRT, VMAT IMRT, vDIBH for breast patients, SABR/SBRT in routine clinical use, and with our track record of innovation and technical developments, there will be ample opportunity to develop new techniques and to strengthen the service.